Cargando…
Expression levels of TGF-β1 and CTGF are associated with the severity of Duchenne muscular dystrophy
The present study aimed to analyze the association of transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) expression levels in skeletal muscle with the clinical manifestation of Duchenne muscular dystrophy (DMD). A total of 18 cases of DMD, which were confirmed by routi...
Autores principales: | Song, Yanmin, Yao, Shuai, Liu, Yunhai, Long, Lili, Yang, Huan, Li, Qiuxiang, Liang, Jinghui, Li, Xinxin, Lu, Yuling, Zhu, Haoran, Zhang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377242/ https://www.ncbi.nlm.nih.gov/pubmed/28413459 http://dx.doi.org/10.3892/etm.2017.4105 |
Ejemplares similares
-
Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients
por: Chen, Menglong, et al.
Publicado: (2020) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021) -
Serum Creatinine Level: A Supplemental Index to Distinguish Duchenne Muscular Dystrophy from Becker Muscular Dystrophy
por: Zhang, Huili, et al.
Publicado: (2015) -
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
por: Yao, Shanshan, et al.
Publicado: (2021)